MIACH Orthopaedics Secures $22.5 Million Series A Financing Company to Continue FDA-Approved Clinical Trials of Bridge-Enhanced® ACL Repair (BEAR®)
Home » MIACH Orthopaedics Secures $22.5 Million Series A Financing Company to Continue FDA-Approved Clinical Trials of Bridge-Enhanced® ACL Repair (BEAR®)
MIACH Orthopaedics Secures $22.5 Million Series A Financing Company to Continue FDA-Approved Clinical Trials of Bridge-Enhanced® ACL Repair (BEAR®)2018-09-172018-09-18http://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.pngRedPepper Mergershttp://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.png200px200px
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.